ITMI20022549A1 - Composizione quaternaria comprendente come sostanza attiva la propolis. - Google Patents

Composizione quaternaria comprendente come sostanza attiva la propolis.

Info

Publication number
ITMI20022549A1
ITMI20022549A1 IT002549A ITMI20022549A ITMI20022549A1 IT MI20022549 A1 ITMI20022549 A1 IT MI20022549A1 IT 002549 A IT002549 A IT 002549A IT MI20022549 A ITMI20022549 A IT MI20022549A IT MI20022549 A1 ITMI20022549 A1 IT MI20022549A1
Authority
IT
Italy
Prior art keywords
propolis
active substance
composition including
quaternary composition
including propolis
Prior art date
Application number
IT002549A
Other languages
English (en)
Inventor
Tiziana Canal
Fabio Carli
Mora Paolo Corvi
Original Assignee
Actimex S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actimex S R L filed Critical Actimex S R L
Priority to IT002549A priority Critical patent/ITMI20022549A1/it
Priority to SI200330602T priority patent/SI1572155T1/sl
Priority to EP03812165A priority patent/EP1572155B1/en
Priority to PCT/EP2003/013560 priority patent/WO2004050063A1/en
Priority to JP2004556263A priority patent/JP2006511511A/ja
Priority to ES03812165T priority patent/ES2274318T3/es
Priority to CNB2003801048012A priority patent/CN100398090C/zh
Priority to RU2005120766/15A priority patent/RU2005120766A/ru
Priority to US10/537,190 priority patent/US7763282B2/en
Priority to DE60308899T priority patent/DE60308899T2/de
Priority to CA002508034A priority patent/CA2508034A1/en
Priority to AU2003296602A priority patent/AU2003296602A1/en
Priority to AT03812165T priority patent/ATE341307T1/de
Publication of ITMI20022549A1 publication Critical patent/ITMI20022549A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988—Honey; Royal jelly, Propolis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
IT002549A 2002-12-02 2002-12-02 Composizione quaternaria comprendente come sostanza attiva la propolis. ITMI20022549A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT002549A ITMI20022549A1 (it) 2002-12-02 2002-12-02 Composizione quaternaria comprendente come sostanza attiva la propolis.
SI200330602T SI1572155T1 (sl) 2002-12-02 2003-12-02 Kvartarne spojine, ki obsegajo propolis kot aktivno snov
EP03812165A EP1572155B1 (en) 2002-12-02 2003-12-02 Quaternary compounds comprising propolis as the active substance
PCT/EP2003/013560 WO2004050063A1 (en) 2002-12-02 2003-12-02 Quaternary compounds comprising propolis as the active substance
JP2004556263A JP2006511511A (ja) 2002-12-02 2003-12-02 活性物質としてプロポリスを有する四種組成物
ES03812165T ES2274318T3 (es) 2002-12-02 2003-12-02 Compuestos cuaternarios que comprenden propolis como sustancia activa.
CNB2003801048012A CN100398090C (zh) 2002-12-02 2003-12-02 包含蜂胶作为活性物质的四元组合物
RU2005120766/15A RU2005120766A (ru) 2002-12-02 2003-12-02 Четвертичные соединения, содержащие прополис в качестве активного вещества
US10/537,190 US7763282B2 (en) 2002-12-02 2003-12-02 Quaternary compounds comprising propolis as the active substance
DE60308899T DE60308899T2 (de) 2002-12-02 2003-12-02 Quaternäre verbindungen enthaltend propolis als wirkstoff
CA002508034A CA2508034A1 (en) 2002-12-02 2003-12-02 Quaternary compounds comprising propolis as the active substance
AU2003296602A AU2003296602A1 (en) 2002-12-02 2003-12-02 Quaternary compounds comprising propolis as the active substance
AT03812165T ATE341307T1 (de) 2002-12-02 2003-12-02 Quaternäre verbindungen enthaltend propolis als wirkstoff

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002549A ITMI20022549A1 (it) 2002-12-02 2002-12-02 Composizione quaternaria comprendente come sostanza attiva la propolis.

Publications (1)

Publication Number Publication Date
ITMI20022549A1 true ITMI20022549A1 (it) 2004-06-03

Family

ID=32448917

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002549A ITMI20022549A1 (it) 2002-12-02 2002-12-02 Composizione quaternaria comprendente come sostanza attiva la propolis.

Country Status (12)

Country Link
US (1) US7763282B2 (it)
EP (1) EP1572155B1 (it)
JP (1) JP2006511511A (it)
CN (1) CN100398090C (it)
AT (1) ATE341307T1 (it)
AU (1) AU2003296602A1 (it)
CA (1) CA2508034A1 (it)
DE (1) DE60308899T2 (it)
ES (1) ES2274318T3 (it)
IT (1) ITMI20022549A1 (it)
RU (1) RU2005120766A (it)
WO (1) WO2004050063A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006025790A (ja) * 2004-06-17 2006-02-02 Morikawa Kenkoudou Kk プロポリスの水への可溶化方法
JP4947758B2 (ja) * 2004-06-17 2012-06-06 森川健康堂株式会社 プロポリス抽出物の粉末状組成物及びその製造方法
CN1311815C (zh) * 2005-05-08 2007-04-25 浙江大学 亚微米蜂胶微胶囊的制备方法
ITPD20050224A1 (it) * 2005-07-19 2007-01-20 Actimex Srl Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego
IT1395351B1 (it) * 2009-07-09 2012-09-14 Axioma Srl Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli
JP4574742B1 (ja) * 2010-04-08 2010-11-04 有限会社ミールジャパン プロポリス組成物
JP5725832B2 (ja) * 2010-12-16 2015-05-27 株式会社クラレ 化学的機械的研磨法およびそれに用いられるスラリー
CN103491968A (zh) 2011-01-08 2014-01-01 彭妮·科琳·凯恩 蜜蜂粉霜组合物、提取方法及其用途
EP3169321B1 (en) * 2014-07-18 2020-07-15 Manuka Health New Zealand Limited Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
GR1009068B (el) * 2016-05-09 2017-07-05 Πετρος Παναγιωτη Παναγιωτου Θεραπευτικο σκευασμα για πληγες κατακλισεων που, ψεκαζομενο επανω στην πληγη, δημιουργει επουλωτικη κρουστα - επιδεσμο
WO2022040772A1 (en) * 2020-08-25 2022-03-03 Wenmin Du Instant traditional-chinese-medicine dried powder for decoction and method of preparing and using same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876816A (en) * 1972-10-25 1975-04-08 Dynapol Corp Nonabsorbable, nonnutritive sweeteners
DE3279437D1 (en) * 1982-12-01 1989-03-16 Zenon M Sosnowski Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same
JPS60188036A (ja) * 1984-03-08 1985-09-25 Riken Vitamin Co Ltd グリチルリチン酸またはその塩類の呈味改善法
US6005100A (en) * 1992-12-02 1999-12-21 Kabushiki Kaisha Hayashibara Seitbutsu Kagaku Kenkyujo Trehalose composition for prolonging product shelf life
CN1081831A (zh) * 1993-05-20 1994-02-16 李前远 一种保健口香糖及其制备方法
US5922324A (en) * 1995-01-31 1999-07-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Propolis extract with improved water-solubility
JPH09206003A (ja) * 1996-02-06 1997-08-12 San Herusen Kk プロポリスパウダーの製造方法
JPH1025255A (ja) * 1996-07-11 1998-01-27 Taisho Pharmaceut Co Ltd 溶解性の改善された難溶性薬剤
JP2784349B2 (ja) * 1996-08-26 1998-08-06 アピ株式会社 食品用プロポリス組成物及びその製造方法
US20030104018A1 (en) * 1996-12-31 2003-06-05 Griscom Bettle Skin product having micro-spheres, and processes for the production thereof
CZ291842B6 (cs) * 1997-03-13 2003-06-18 Hexal Ag Farmaceutická formulace
IT1304190B1 (it) * 1998-12-18 2001-03-08 Euphar Group Srl Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
JP2000316498A (ja) * 1999-04-30 2000-11-21 Piizu Communications:Kk 水抽出プロポリスエキス及びその製造方法
JP2001010963A (ja) * 1999-06-29 2001-01-16 Api Co Ltd プロポリス粉末組成物及びその製造方法
ITMI20021074A1 (it) * 2002-05-20 2003-11-20 Actimex S R L Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione

Also Published As

Publication number Publication date
ATE341307T1 (de) 2006-10-15
RU2005120766A (ru) 2006-02-10
US7763282B2 (en) 2010-07-27
JP2006511511A (ja) 2006-04-06
US20060013891A1 (en) 2006-01-19
CN100398090C (zh) 2008-07-02
EP1572155B1 (en) 2006-10-04
WO2004050063A1 (en) 2004-06-17
EP1572155A1 (en) 2005-09-14
CA2508034A1 (en) 2004-06-17
ES2274318T3 (es) 2007-05-16
CN1720023A (zh) 2006-01-11
DE60308899D1 (de) 2006-11-16
DE60308899T2 (de) 2007-05-10
AU2003296602A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
EA200301275A1 (ru) Капсулы для ингаляции
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
DK1372608T3 (da) Medicinske aerosolformuleringer
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
ATE341307T1 (de) Quaternäre verbindungen enthaltend propolis als wirkstoff
WO2004017943A3 (en) Non-vesicular cationic lipid formulations
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
SI1622447T1 (sl) Vodni, plavajoäś koncentrat pendimetalina
WO2005107709A3 (en) Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
WO2004071386A3 (en) Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use
ATE455471T1 (de) Pulverförmige zusammensetzungen von fettlöslichen substanzen
SE9902742D0 (sv) New pharmaceutical formultion